Lei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lei Chen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chunhua Tony Hu
Department of Chemistry and Molecular Design Institute, New York University, New York, New York 10003, United States
1 shared publication - DingPing Feng
College of Animal Science and Technology Northwest A&F University Yangling China
1 shared publication - GuoYan Wang
College of Animal Science and Technology Northwest A&F University Yangling China
1 shared publication Honggang Xiang
Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
1 shared publication- Junhu Yao
College of Animal Science and Technology, Northwest A&F University, Yangling, China
1 shared publication - Lu Deng
College of Animal Science and Technology Northwest A&F University Yangling China
1 shared publication
Latest Publications
- Open Access
- 3 July 2025
- Published by Wiley in Animal Research and One Health
- Vol. 4 (2) , 198-212
Compensation Response to Hepatic Gluconeogenesis via β‐Hydroxybutyrylation of FBP1 and PCK1 in Dairy Cows
Perinatal cows are often in a state of negative energy balance (NEB), and hepatic gluconeogenesis is an important energy source in ruminants. NEB can lead to metabolic disorders such as ketosis. β‐Hydroxybutyrate (BHB) is a major ketone body that acts as an energy substrate; however, its role and mechanism in hepatic gluconeogenesis in perinatal cows are unclear. The aim of this study was to investigate the compensatory effects of BHB in hepatic gluconeogenesis in dairy cows, particularly its effect on fructose 1,6‐bisphosphatase 1 (FBP1) and phosphoenolpyruvate carboxykinase 1 (PCK1), which are key rate‐limiting enzymes in gluconeogenesis. We performed Kbhb proteomic analysis of liver tissue samples from perinatal cows and found a significant enrichment of the gluconeogenic pathway. When bovine hepatocytes were treated with different concentrations of BHB, there was a significant increase in cellular glucose production and FBP1/PCK1 activity. With regard to the underlying mechanisms, the findings implied that Kbhb of FBP1/PCK1 may occur in a BHB concentration‐ and time‐dependent manner. Furthermore, Kbhb of FBP1/PCK1 was found to be regulated by histone acetyltransferase p300 (p300) and histone deacetylase (HDACs). Mass spectrometry analysis revealed that Kbhb occurred at lysine (K) 43 of FBP1 and K191 of PCK1. In conclusion, our results demonstrate that the compensatory effects of BHB induced an increase in the enzymatic activity of FBP1 and PCK1 through Kbhb modification at the K43 site of FBP1 and the K191 site of PCK1; in turn, it enhances the hepatic gluconeogenesis of cows to certain BHB concentrations.
- 3 July 2025
- Published by Wiley in Animal Research and One Health
- Vol. 4 (2) , 198-212
Open AccessCompensation Response to Hepatic Gluconeogenesis via β‐Hydroxybutyrylation of FBP1 and PCK1 in Dairy Cows
Perinatal cows are often in a state of negative energy balance (NEB), and hepatic gluconeogenesis is an important energy source in ruminants. NEB can lead to metabolic disorders such as ketosis. β‐Hydroxybutyrate (BHB) is a major ketone body that acts as an energy substrate; however, its role and mechanism in hepatic gluconeogenesis in perinatal cows are unclear. The aim of this study was to investigate the compensatory effects of BHB in hepatic gluconeogenesis in dairy cows, particularly its effect on fructose 1,6‐bisphosphatase 1 (FBP1) and phosphoenolpyruvate carboxykinase 1 (PCK1), which are key rate‐limiting enzymes in gluconeogenesis. We performed Kbhb proteomic analysis of liver tissue samples from perinatal cows and found a significant enrichment of the gluconeogenic pathway. When bovine hepatocytes were treated with different concentrations of BHB, there was a significant increase in cellular glucose production and FBP1/PCK1 activity. With regard to the underlying mechanisms, the findings implied that Kbhb of FBP1/PCK1 may occur in a BHB concentration‐ and time‐dependent manner. Furthermore, Kbhb of FBP1/PCK1 was found to be regulated by histone acetyltransferase p300 (p300) and histone deacetylase (HDACs). Mass spectrometry analysis revealed that Kbhb occurred at lysine (K) 43 of FBP1 and K191 of PCK1. In conclusion, our results demonstrate that the compensatory effects of BHB induced an increase in the enzymatic activity of FBP1 and PCK1 through Kbhb modification at the K43 site of FBP1 and the K191 site of PCK1; in turn, it enhances the hepatic gluconeogenesis of cows to certain BHB concentrations.
- Open Access
- 1 December 2016
- Published by Springer Nature in BMC Biochemistry
- Vol. 17 (1) , 19
Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer
Gamma glutamylcyclotransferase (GGCT) has been proved to be involved in various cancers, but the biological function of GGCT in gastric cancer is still largely unknown. The expression level of GGCT was evaluated by informatics analyses based on the Oncomine database. GGCT gene was then effectively knocked down via lentivirus mediated short hairpin RNA (shRNA) system. Then a series of functional assays, including MTT, colony formation and flow cytometry analysis were conducted on gastric cancer cells following GGCT knockdown. We found GGCT is commonly up-regulated in gastric cancer tissues. Furthermore, MTT analysis showed that GGCT depletion significantly inhibited cell proliferation in MGC80-3 and AGS cells. Colony formation assay revealed that depletion of GGCT reduced the colony formation ability in gastric cancer cells. What’s more, cell cycle analysis showed that depletion of GGCT induced gastric cancer cell cycle arrested G2/M phase. More importantly, cell apoptosis analysis further revealed that GGCT inhibition induced early and late cell apoptosis in gastric cancer. This study suggests GGCT is essential for gastric cancer proliferation and its downregulation may provide a potential anticancer therapy for gastric cancer.
- 1 December 2016
- Published by Springer Nature in BMC Biochemistry
- Vol. 17 (1) , 19
Open AccessKnockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer
Gamma glutamylcyclotransferase (GGCT) has been proved to be involved in various cancers, but the biological function of GGCT in gastric cancer is still largely unknown. The expression level of GGCT was evaluated by informatics analyses based on the Oncomine database. GGCT gene was then effectively knocked down via lentivirus mediated short hairpin RNA (shRNA) system. Then a series of functional assays, including MTT, colony formation and flow cytometry analysis were conducted on gastric cancer cells following GGCT knockdown. We found GGCT is commonly up-regulated in gastric cancer tissues. Furthermore, MTT analysis showed that GGCT depletion significantly inhibited cell proliferation in MGC80-3 and AGS cells. Colony formation assay revealed that depletion of GGCT reduced the colony formation ability in gastric cancer cells. What’s more, cell cycle analysis showed that depletion of GGCT induced gastric cancer cell cycle arrested G2/M phase. More importantly, cell apoptosis analysis further revealed that GGCT inhibition induced early and late cell apoptosis in gastric cancer. This study suggests GGCT is essential for gastric cancer proliferation and its downregulation may provide a potential anticancer therapy for gastric cancer.